Tatva Chintan Pharma Chem Limited will host a virtual one-to-one analyst meeting with Tamohara Investment Managers Pvt. Ltd. on July 30, 2026. The company disclosed the engagement schedule to the Bombay Stock Exchange and National Stock Exchange of India Limited on July 24, 2026, in compliance with market transparency norms. This interaction provides investors and financial institutions an opportunity to discuss the company’s operational and financial performance based on existing public disclosures.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ishwar Nayi, Company Secretary and Compliance Officer of Tatva Chintan Pharma Chem Limited, signed the intimation letter submitted to the exchanges. The company emphasized that the meeting schedule is subject to change if necessary.

Meeting Details

Information Scope

Tatva Chintan Pharma Chem Limited stated that it will refer only to publicly available information during the interaction. The company explicitly confirmed that no confidential or unpublished price sensitive information (UPSI) will be shared during the meeting. This ensures compliance with insider trading regulations while facilitating investor dialogue.

The details of the meeting and related disclosures are available on the company’s website at www.tatvachintan.com for public reference.

Tatva Chintan Pharma Chem Limited has scheduled a virtual one-to-one meeting with Motilal Oswal AMC on July 31, 2026. The engagement is part of the company’s ongoing investor relations activities and aims to provide financial institutions with updates based on publicly available data. This interaction ensures transparency and adherence to regulatory disclosure norms without sharing any unpublished price-sensitive information (UPSI).

The meeting was intimated to the Bombay Stock Exchange and the National Stock Exchange of India Limited on July 24, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ishwar Nayi, Company Secretary and Compliance Officer, signed the disclosure, confirming that discussions will be strictly limited to information already available to the public.

Meeting Details

The schedule for the investor interaction is outlined below:

Regulatory Compliance

The company emphasized that no confidential or UPSI will be shared during the session. All information discussed will refer only to what is already accessible through official channels. The intimation is also available on the company’s website at www.tatvachintan.com . Any changes to the schedule will be communicated separately.